BioProcess International Europe is part of the Informa Connect Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Aubrey Tiernan is a Senior Scientist in the Gene Therapy Division of Ultragenyx Pharmaceuticals located in Cambridge, MA, USA. She directed efforts by the cell line group to develop robust screening approaches for generating stable producer cell lines to support clinical trials and late-stage readiness efforts. She received her B.S. from UMass, Amherst and her Ph.D. from Georgia Institute of Technology in Chemical & Biomolecular Engineering. Prior to work at Ultragenyx, her research focused on developing a pancreatic substitute via engineering of non-beta cells for insulin secretion and investigating strategies for enhancing production from intrinsically low-producing cell lines.